
ANLON HEALTHCARE LIMITED (AHCL) Share Price near 52-week high as AHCL trades at Rs 31.04
Updated: 25 Sept 2026 • 11:19 am
Posted by:

AHCL Share Price is trading at Rs 31.04, up 7.97% today, and remains close to its 52-week high after moving between Rs 27.70 and Rs 31.50 in the latest trade window. Anlon Healthcare Limited (AHCL) carries a market capitalisation of Rs 1,580.73 crore, which places the move in a clear market-cap context for investors tracking AHCL Share Price Today and AHCL Stock News. The latest Univest data confirms the price event, while the record itself is relevant because the stock is trading close to its yearly high without any company-specific catalyst being identified in the latest Univest figures. For readers following AHCL Share Price, the key question is how the price move compares with valuation, sector benchmarks and recent financial performance.
AHCL Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 31.04 |
| Previous Close | Rs 28.75 |
| Today's Move | +Rs 2.29 (+7.97%) |
| Open | Rs 28.67 |
| High | Rs 31.5 |
| Low | Rs 27.7 |
| Market Capitalisation | Rs 1,580.73 crore |
ANLON HEALTHCARE LIMITED (AHCL) traded at Rs 31.04 versus the previous close of Rs 28.75, a rise of 7.97%. The stock opened at Rs 28.67, reached a high of Rs 31.5 and touched a low of Rs 27.7.
AHCL Share Price opened at Rs 28.67, compared with the previous close of Rs 28.75, and later traded at Rs 31.04. That is a day gain of Rs 2.29, or 7.97%, with the high at Rs 31.50 and the low at Rs 27.70. The stock is therefore trading very close to its 52-week high, which is the main reason AHCL Share Price Today is drawing attention in AHCL Stock News and AHCL Share Price Update searches. The price action confirms the near-peak event, but the figures do not establish a company-specific catalyst. For investors scanning AHCL Share Price Live, the move is relevant because the stock is holding near its yearly high while moving sharply within a relatively tight intraday band. AHCL Share Price now shifts the focus to what the fundamentals and sector comparisons show about the latest move.
ANLON HEALTHCARE LIMITED (AHCL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,580.73 crore |
| P/E Ratio | 53.59x |
| P/B Ratio | 5.24x |
| ROE | 18.73% |
| ROCE | 21.98% |
| EPS | Rs 0.54 |
| Book Value Per Share | Rs 5.49 |
| Dividend Yield | 0% |
ANLON HEALTHCARE LIMITED (AHCL) fundamental metrics show P/E 53.59x, P/B 5.24x, ROE 18.73%, ROCE 21.98%. These figures provide context only and are not a buy or sell signal.
ANLON HEALTHCARE LIMITED has a market capitalisation of Rs 1580.73 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 53.59x, P/B at 5.24x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.73% and ROCE of 21.98%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.54, book value per share of Rs 5.49, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.98x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 53.59x |
| Benchmark Median P/E | 27.98x |
| Benchmark Average P/E | 42.05x |
| Benchmark P/E Range | 0x to 757.76x |
| Company P/B Ratio | 5.24x |
| Benchmark Median P/B | 2.91x |
| Company ROE | 18.73% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 21.98% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 1,580.73 crore |
| Benchmark Median Market Cap | Rs 793.62 crore |
ANLON HEALTHCARE LIMITED (AHCL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
ANLON HEALTHCARE LIMITED (AHCL) has a P/E ratio of 53.59x, which is above the benchmark median of 27.98x, a difference of +91.53%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
ANLON HEALTHCARE LIMITED (AHCL) has a ROE of 18.73%, which is above the benchmark median of 11.7%, a difference of +60.09%. ANLON HEALTHCARE LIMITED (AHCL) has a ROCE of 21.98%, which is above the benchmark median of 13.46%, a difference of +63.3%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Jagsonpal Pharmaceuticals Ltd. | JAGSNPHARM | 1,608.37 | 35.37 | 6.98 | 18.19 | 22.69 |
| Accent Microcell Ltd. | ACCENTMIC | 1,617.46 | 36.88 | 5.87 | 18.65 | 24.88 |
| Amrutanjan Health Care Ltd. | AMRUTANJAN | 1,474.01 | 27.37 | 3.94 | 16.62 | 22.46 |
| NGL Fine-Chem Ltd. | NGLFINE | 1,758.64 | 31.29 | 5.15 | 15.74 | 16.88 |
| Fermenta Biotech Ltd. | FERMENTA | 1,395.47 | 23.42 | 3.43 | 18.36 | 21.99 |
ANLON HEALTHCARE LIMITED (AHCL) has a P/E ratio of 53.59x compared with the displayed peer median of 31.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.73% compares with a peer median of 18.19% across the companies shown in the table. ROCE stood at 21.98% versus the displayed peer median of 22.46%, providing a capital-efficiency comparison. ANLON HEALTHCARE LIMITED (AHCL) has a market capitalisation of Rs 1,580.73 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching AHCL
- AHCL Share Price is trading at Rs 31.04, up 7.97% from the previous close of Rs 28.75.
- The latest trade range was Rs 27.70 to Rs 31.50, keeping AHCL near its 52-week high.
- Market capitalisation stands at Rs 1,580.73 crore, which is above the industry median.
- P/E is 53.59, while P/B is 5.24, both above the industry median figures.
- ROE of 18.73% and ROCE of 21.98% remain above the same-industry median values.
About ANLON HEALTHCARE LIMITED
ANLON HEALTHCARE LIMITED operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. AHCL Share Price readers tracking the company under NSE and BSE market searches are looking at a listed business that now carries a market capitalisation of Rs 1,580.73 crore. The latest financial figures show revenue at Rs 875.For AHCL Share Price and AHCL Company News searches, these are the core verified company facts currently in view.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is AHCL Share Price near its 52-week high?
Ans. AHCL Share Price is near its 52-week high because it traded at Rs 31.04 after moving from a previous close of Rs 28.75. The latest figures confirm the price event without identifying a company-specific catalyst.
What is AHCL Share Price today?
Ans. AHCL Share Price today is Rs 31.04, up Rs 2.29 or 7.97% from the previous close. The intraday range was Rs 27.70 to Rs 31.50, which keeps the stock close to its yearly high.
How does AHCL Share Price compare with its market cap?
Ans. AHCL Share Price corresponds to a market capitalisation of Rs 1,580.73 crore. That is above the same-industry median market cap of Rs 793.62 crore and places the company above the industry midpoint.
Is AHCL expensive on valuation?
Ans. AHCL Share Price is paired with a P/E ratio of 53.59 and a P/B ratio of 5.24. Both are above the same-industry median figures, while ROE and ROCE are also above the benchmark medians.
What do AHCL earnings and book value show?
Ans. AHCL Share Price is supported by EPS of Rs 0.54 and book value per share of Rs 5.49. These figures help frame the valuation discussion alongside the company’s return ratios and revenue trend.
Does AHCL pay a dividend?
Ans. AHCL Share Price is linked to a dividend yield of 0 in the latest figures, so there is no current yield shown. Investors tracking AHCL usually pair that with earnings, book value and valuation ratios.
How does AHCL compare with peers?
Ans. AHCL Share Price stands alongside peers such as Jagsonpal Pharmaceuticals, Accent Microcell and Amrutanjan Health Care. Its market cap is in a similar band, but its P/E is higher than those three companies.
What should investors monitor next for AHCL Share Price?
Ans. Investors monitoring AHCL Share Price can watch the next price update, valuation ratios, revenue trend and net profit figures. Those are the main verified data points currently available for the stock.
Track AHCL Share Price on Univest
Use ANLON HEALTHCARE LIMITED (AHCL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track AHCL Share Price on Univest to follow the latest price, 52-week levels, market cap, valuation ratios, financial results and company updates in one place. Univest also helps readers review AHCL Share Price Today alongside sector and peer context without needing to piece together the figures separately.
Recent Articles

Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
13 November 2026

Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
13 November 2026

Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
13 November 2026

Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
13 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
SC Agrotech Bonus Issue and Stock Split: 4:5 Bonus and 1:10 Split Proposed as the Stock Locks a 5% Upper Circuit at Rs 62.38, Q2 Profit Up 48 Times and What Shareholders Should Check Before the 11 December EGM

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





